Case Study: Strategic R&D Leadership for Dermatology-Driven Growth at Incyte

Case Study: Strategic R&D Leadership for Dermatology-Driven Growth at Incyte

The Mandate: Bridging Science and Commerce

As Incyte accelerated efforts to scale its dermatology franchise, the company engaged Intelisci to lead the appointment of a Divisional Vice President, Dermatology Discovery. This was a mission-critical role designed to fuel portfolio expansion and serve as a strategic partner to the executive team.

This was not just a scientific leadership hire; it was a commercially informed, cross-functional leadership mandate. The successful candidate needed to:

• Shape Incyte’s dermatology discovery and early development strategy.

• Serve as an advisor to the CSO, CEO, and broader R&D leadership.

• Make confident, data-driven recommendations on asset progression, external partnerships, and go/no-go decisions.

• Lead a large group of scientists across discovery, translational science, biomarkers, and external innovation.

• Drive significant pipeline expansion in a high-priority growth area.

  
  

The Intelisci Search Strategy

The role required a rare blend of deep scientific credibility, dermatology/immunology expertise, and seasoned executive presence. To navigate this complex landscape, Intelisci deployed a multi-layered methodology:

1. Strategic Landscape Mapping

The commercial landscape for inflammatory dermatology is exceptionally complex. Intelisci leveraged its Scientific Advisory Board (SAB) to deeply understand the commercial trends and identify the most promising companies in the space. This allowed for the identification of a precise "target universe" of organizations where such a leader would exist.

2. Expert Network & Proactive Sourcing

Intelisci executed a targeted search across biotech, large-cap pharma, and academia. This included:

• SME Outreach: Approaching over 100 high-level academics and industry Subject Matter Experts (SMEs) for recommendations and referrals.

• Technical Mining: Identifying a network of candidates through proprietary search methodology and the mining of scientific publication records.

• The Breakthrough: Ultimately, the SAB referrals led to the introduction of the successful candidate, Dr. Ian Anderson.

  
  

3. Professional Due Diligence

Once the lead candidate was selected, Intelisci spoke at length with his peers for professional due diligence. This went beyond standard references; it was designed to provide the Incyte CSO with a nuanced understanding of the candidate’s specific strengths and opportunities to maximize his impact within the organization.

Search Metrics

• Candidates Approached: 225

• Qualification Calls: 81

• SME/Academic Referrals: 100+

• Referred Candidates: 18

• Submitted Candidates: 19

• Interviewed: 6

• Placement: 1

• Search Duration: 3 months.

The Outcome: Dr. Ian Anderson

Intelisci successfully placed Dr. Ian Anderson, a highly respected leader whose background spans discovery, translational science, and portfolio strategy across companies including Cambridge Antibody Technology, AZ, MedImmune, Janssen Pharmaceuticals, and Aclaris.

Ian brings to Incyte:

• 30+ years of scientific leadership with success in advancing programs to IND and NDA.

• Deep credentials in external partnerships and go/no-go decisions tied to market insight.

• C-suite engagement capabilities to serve as a strategic voice at the governance table.

• Proven ability to build and motivate teams across discovery and clinical sciences.

  
  

"I see enormous opportunity to expand the dermatology portfolio and build a discovery engine that’s aligned to commercial strategy and patient need..." — Dr. Ian Anderson 

Business Impact

With Dr. Anderson in place, Incyte now possesses a strategic operator to accelerate the buildout of its dermatology pipeline and serve as a key advisor on investment prioritization. This hire strengthens Incyte’s ability to execute its growth strategy and positions the R&D organization to support broader commercial ambitions across inflammation and immunology.